万基遗传 MYGN 深 沪
已收盘 10-31 16:00:00 美东时间
8.04
+0.090
+1.13%
华盛通- 最 高8.105
- 今 开7.93
- 成交量 90.40万股
- 最 低 7.80
- 昨 收 7.95
- 总市值 7.48亿
- 52周最高 17.83
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.76
- 委 比 -51.95%
- 总股本 9304.46万
- 历史最高 50.44
- 量 比 1.05
- 振 幅 3.84%
- 历史最低 3.76
- 每 手 1
- 风险率 4.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Exploring Myriad Genetics's Earnings Expectations
Myriad Genetics (NASDAQ:MYGN) is set to give its latest quarterly earnings repo...
11-01 04:01
Myriad Genetics Announces Post-Hoc Analysis Of PRIME Study Showing Treatment Informed By GeneSight Test Led To Faster Initial Remission And Response In Patients With MDD
Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that
10-31 21:08
Neogen names Bryan Riggsbee as CFO
Neogen (NEOG) said on Thursday it has appointed Bryan Riggsbee as its new Chief Financial Officer, effective November 3. Riggsbee will oversee the company’s global finance organization and join the ex...
10-30 21:11
金色早报丨Myriad疑似将上线BSC网络 VIRTUAL24小时涨幅达55.0%
头条：Myriad或上线BSC，CZ表示支持，VIRTUAL涨55%。行情显示BTC涨0.7%，ETH涨0.68%，XRP涨4.3%。Solana联创称可建以太坊L1跨链桥，无需修改以太坊。Mike Selig被提名CFTC主席，将推动加密中心。乌克兰联合14国发表和平声明。数字银行Majority上线稳定币转账，AI平台Bankr SDK支持新协议，Coinbase CEO建议链上融资。年度稳定币转账突破50万亿美元，以太坊与Base领先。贝莱德投5亿于Avalanche。Coinbase进入集合竞价模式。Kraken Q3营收增114%。巨鲸加仓173.6枚BTC，多单近3亿。麻吉爆仓后只剩113万美元。10年期国债收益率跌破4%，提振宽松预期。特朗普宣布对加拿大加征关税。代理型AI强调自主决策与学习能力。
10-26 01:41
新浪财经ESG：万基遗传 MSCI（明晟）ESG评级调升至AA
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
10-25 07:00
Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel
Myriad Genetics has added the F8 and FXN genes to its Foresight Carrier Screen Universal Plus Panel, aligning with American College of Medical Genetics and Genomics recommendations. F8 is linked to hemophilia A, a bleeding disorder, while FXN is associated with Friedreich's ataxia, a neurodegenerative disease. The expansion enhances the panel's ability to detect carriers of inherited conditions, aiding informed family planning decisions.
10-14 12:00
Myriad Genetics Finalizes CFO Separation Agreement
Myriad Genetics ( ($MYGN) ) just unveiled an update. On October 1, 2025, Myriad...
10-08 04:36
Myriad Genetics Announces Leadership Change in Accounting
Myriad Genetics ( ($MYGN) ) has shared an announcement. On September 29, 2025, ...
10-04 04:48
Myriad Genetics And SOPHiA GENETICS Collaborate To Develop And Provide Pharmaceutical Companies With Innovative Global Liquid Biopsy Companion Diagnostic Test
Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (NASDAQ:SOPH), an AI technology company transforming precision medicine, announced a strategic
09-23 20:02
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
Myriad Genetics announced that The Lancet Oncology published a study highlighting the performance of its Precise MRD test in patients with oligometastatic clear-cell renal cell carcinoma (ccRCC). The study demonstrated that the test can detect circulating tumor DNA (ctDNA) levels in patients with very low tumor burden, potentially allowing patients to delay or avoid systemic treatments. Key findings include: 94% of patients tested at baseline had...
09-04 23:00
